Why insider trading matters?

When insiders buy shares on the open market, this can thus be regarded as a strong endorsement by those that know the company the best -- they are literally betting their own money on the company's future. Insider selling, however, is not necessarily meaningful in any way, as there is a range of reasons for insiders to liquidate (some) of the shares they own.

- Seeking Alpha
Royalty Pharma plc (RPRX)


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-06-24 Urist Marshall EVP, Research & Investments Sell 23,333 $43.19 $1,007,694 No
2022-06-08 Reddoch James F. EVP & Chief Scientific Officer Sell 100,000 $41.56 $4,155,900 No
2022-05-27 Reddoch James F. EVP & Chief Scientific Officer Sell 75,000 $41.08 $3,081,008 No
2022-05-27 Lloyd George W. EVP, Investments & GC Sell 100,000 $40.29 $4,029,091 No
2022-05-23 Lloyd George W. EVP, Investments & GC Sell 100,000 $40.27 $4,026,770 No
2022-05-19 Reddoch James F. EVP & Chief Scientific Officer Sell 75,000 $40.44 $3,033,128 No
2022-05-16 Urist Marshall EVP, Research & Investments Sell 23,333 $39.85 $929,836 No
2022-03-21 RIGGS RORY B Director Sell 169,089 $39.43 $6,667,521 No
2021-12-29 RIGGS RORY B Director Sell 184,448 $40.12 $7,400,767 No
2021-11-17 Lloyd George W. EVP, Investments & GC Sell 250,000 $42.39 $10,596,693 Yes
2021-11-17 RIGGS RORY B Director Sell 214,389 $42.34 $9,076,492 No
2021-07-14 Reddoch James F. EVP, Research & Investments Sell 17,934 $42.01 $753,369 No
2021-06-29 RIGGS RORY B Director Sell 1,314,912 $42.11 $55,370,134 No
2021-06-10 Lloyd George W. EVP, Investments & GC Sell 70,000 $46.49 $3,254,369 No
2021-06-07 Urist Marshall EVP & Co-Head of R&I Sell 33,134 $46.08 $1,526,721 No
2021-06-08 Lloyd George W. EVP, Investments & GC Sell 252,500 $46.01 $11,616,797 No
2021-06-08 Reddoch James F. EVP, Research & Investments Sell 200,000 $45.55 $9,110,689 No
2021-06-02 Urist Marshall EVP & Co-Head Research & Inv. Sell 14,566 $41.52 $604,850 No
2021-06-02 Reddoch James F. EVP, Research & Investments Sell 50,000 $42.13 $2,106,560 No
2021-06-02 Lloyd George W. EVP, Investments & GC Sell 62,500 $42.12 $2,632,512 No
2021-05-21 Urist Marshall EVP & Co-Head Research & Inv. Sell 2,000 $41.08 $82,159 No
2021-04-14 Lloyd George W. EVP, Investments & GC Sell 69,822 $42.13 $2,941,920 No
2021-04-14 Reddoch James F. EVP, Research & Investments Sell 55,714 $42.10 $2,345,593 No
2021-04-12 Lloyd George W. EVP, Investments & GC Sell 449 $42.32 $19,002 No
2021-04-12 Reddoch James F. EVP, Research & Investments Sell 359 $42.32 $15,193 No
2021-03-22 Reddoch James F. EVP, Research & Investments Sell 43,927 $46.32 $2,034,519 No
2021-03-22 Lloyd George W. EVP, Investments & GC Sell 54,729 $46.32 $2,535,226 No
2021-03-03 Coyne Terrance P. EVP & CFO Sell 100,000 $44.78 $4,478,450 No
2021-03-02 Lloyd George W. EVP, Investments & GC Sell 125,000 $46.94 $5,867,148 No
2021-03-02 Reddoch James F. EVP, Research & Investments Sell 100,000 $46.92 $4,692,158 No

Insider Smart

Altimmune, Inc. (ALT) - Venrock Healthcare Capital Partners III, L.P., 10%-owner of ALT bought 1.3M shares in late May then added another 1.5M shares in June with an averaged ~$8 per share. 10 days after the accumulation, ALT price jumped to $10.

Insider Smart

ROYAL CARIBBEAN CRUISES (RCL) - Thompson Donald, Director of RCL feels safe and made a move. The only insiders bought RCL post crash.